Antibodies reactive with the cryptococcal capsular polysaccharide glucuronoxylomannan are present in sera from children with and without human immunodeficiency virus infection

Journal of Infectious Diseases

Volumn 180, Issue 3, 1999, Pages 915-919

  Abadi, Jacobo ^a   Pirofski, Liise Anne ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCURONOXYLMANNAN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; POLYSACCHARIDE; UNCLASSIFIED DRUG;

ADOLESCENT; AGE; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; SEROTYPE; SOCIOECONOMICS; UNITED STATES;

ADOLESCENT; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIBODIES, FUNGAL; ANTIBODY SPECIFICITY; ANTIGENS, FUNGAL; CHILD; CHILD, PRESCHOOL; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HIV INFECTIONS; HIV SERONEGATIVITY; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFANT; POLYSACCHARIDES; REFERENCE VALUES;

EID: 0032825567     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314953     Document Type: Article

References (15)

1. 1. Mitchell TG, Perfect JR. Cryptococcosis in the era of AIDS - 100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev 1995;8: 515-48.
2. 2. Abadi J, Nachman S, Kressel AB, Pirofski L. Cryptococcosis in children with AIDS. Clin Infect Dis 1999;28:309-13.
3. 3. Speed BR, Kaldor J, Cairns B, Pegorer M. Serum antibody response to active infection with Cryptococcus neoformans and its varieties in immunocompetent subjects. J Med Vet Mycol 1996;34:187-93.
4. 4. Seaton RA, Hamilton AJ, Hay RJ, Warrell DA. Exposure to Cryptococcus neoformans var. gattii - a seroepidemiological study. Trans R Soc Trop Med Hyg 1996;90:508-12.
5. 5. Currie BP, Casadevall A. Estimation of the prevalence of cryptococcal infection among patients infected with the human immunodeficiency virus in New York City. Clin Infect Dis 1994;19:1029-33.
6. 6. Zhang H, Zhong Z, Pirofski L. Peptide epitopes recognized by a human anticryptococcal glucuronoxylomannan antibody. Infect Immun 1997;65: 1158-64.
7. 7. DeShaw M, Pirofski L. Antibodies to Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan are ubiquitous in the serum of HIV+ and HIV individuals. Clin Exp Immunol 1995;99:425-32.
8. 8. Pirofski L, Lui R, DeShaw M, Kressel AB, Zhong Z. Analysis of human monoclonal antibodies elicited by vaccination with a Cryptococcus neoformans glucuronoxylomannan capsular polysaccharide vaccine. Infect Immun 1995;63:3005-14.
9. 9. Abadi J, Friedman J, Jefferis R, Mageed R, Pirofski L. Human antibodies elicited by a pneumococcal vaccine express idiotypic determinants indicative of VH3 gene segment usage. J Infect Dis 1998;178:707-16.
10. 10. Pirofski L, Casadevall A. Cryptococcus neoformans: paradigm for the role of antibody in immunity. Zentralbl Bakteriol 1996;284:475-95.
11. 11. Lane CH, Masur H, Edgar LC, et al. Abnormalities of B cell activation and immunoregulation in patients with AIDS. N Engl J Med 1983;309:453-8.
12. 12. Pirofski L, Casadevall A. The use of licensed vaccines for active immunization of the immunocompromised host. Clin Microbiol Rev 1998;11:1-26.
13. 13. Casadevall A, Perfect JR. Ecology of Cryptococcus neoformans. In: Casadevall A, Perfect JR, eds. Cryptococcus neoformans. Washington, DC: American Society for Microbiology Press, 1998:41-70.
14. 14. Roilides E, Black C, Reimer C, Rubin M, Venzon D, Pizzo PA. Serum immunoglobulin G subclasses in children infected with human immunodeficiency virus type 1. Pediatr Infect Dis J 1991;10:134-9.
15. 15. Freijd A, Hammarstrom L, Persson MA, Smith CI. Plasma anti-pneumococcal antibody activity of the IgG class and subclasses in otitis prone children. Clin Exp Immunol 1984;56:233-8.